Palisade Bio Inc (PALI) Stock Price, Quote, News & History

PALINASDAQ
$2.09
0.0452.2%
At close: Sep 4, 5:00 PM EST
$2.08
-0.0097-0.46%
After Hours: Sep 4, 5:30 PM EST

Palisade Bio (PALI) Stock Price, Quote, News & History | Benzinga

Financials

Quarterly
Annual
Name
Revenue
Change
Gross
Change
EBITDA
Change
EBIT
Change
Earnings
Change

Cash Flows

Operating Cash Flow (TTM)
-18.19M
Investing Cash Flow (TTM)
-
Financing Cash Flow (TTM)
137.97M
Free Cash Flow (TTM)
-18.19M
Capital Expenditure (TTM)
-
Net Change in Cash (TTM)
119.78M

Analyst Trends and Forecast

1
Mar
1
Apr
1
Jul
Buy
Hold
Sell
Strong Sell

Analyst Rating and Forecast

12345
4.2
Buy
Strong Buy
Buy
Hold
Sell
Strong Sell

Valuation Metrics

Enterprise Value
$230.46M
PE Ratio (TTM)
3.15
PE Ratio (FWD)
-
PEG Ratio (TTM)
-
PS Ratio (TTM)
648.41
PB Ratio (TTM)
2.93
Earnings Yield % (TTM)
31.78%
Earnings Yield % (FWD)
-11.74%
EV / EBITDA (TTM)
-
Price / EBITDA (TTM)
-
Price / Free Cash Flow (TTM)
-
Book Value / Share
$0.70

Company Debt

Total Debt
-
LT Debt
-
LT Debt Issuance (TTM)
-
LT Debt Repayment (TTM)
-
Total Cash
$125.17M
Debt to Equity
-
Issuance of Debt (TTM)
-
Repayment of Debt (TTM)
-$311.00K

Key Statistics

Open
$2.03
Close
$2.09
Volume / Avg.
1.76M / 2.82M
Day Range
$2.00 - $2.12
52 Wk Range
0.53 - 2.86
Market Cap
$362.54M
P/E Ratio
3.15
Dividend Yield
-
Exchange
NASDAQ
RSI
53
Short Interest
19.17%
Days to Cover
22.04

About

Sector
Health Care
Industry
Biotechnology
Palisade Bio Inc is a clinical-stage biopharma company focused on identifying and developing therapeutics that protect the integrity of the intestinal barrier. Its portfolio consists of a PALI-2108 for the treatment of IBD, including UC and CD, and i...
Show More
Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

FAQ

Q

How do I buy Palisade Bio (PALI) stock?

A

You can purchase shares of Palisade Bio (NASDAQ:PALI) through any online brokerage.

View our list of the best stock brokerages

Q

What is the forecast, or price target, for Palisade Bio (PALI) stock?

A

Palisade Bio has a consensus price target of $10.56.

Q

What is the current price for Palisade Bio (PALI)?

A

The stock price for Palisade Bio (NASDAQ: PALI) is $2.0803 last updated September 4, 2026 at 5:30 PM EDT.

Q

Does Palisade Bio (PALI) pay a dividend?

A

There are no upcoming dividends for Palisade Bio.

Q

When is Palisade Bio (NASDAQ:PALI) reporting earnings?

A

Palisade Bio does not have any upcoming earnings scheduled.

Q

Is Palisade Bio (PALI) going to split?

A

There is no upcoming split for Palisade Bio.

Q

What sector and industry does Palisade Bio (PALI) operate in?

A

Palisade Bio is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.